Cargando…

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer

Inflammation plays a key role in the development of colorectal cancers. We have investigated the relationship between PTGS2 (COX2) polymorphisms and colorectal cancer risk in a hospital based case–control study. We recruited 292 patients with colorectal cancer and 274 controls from new patients admi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, D G, Pontes, C, Guino, E, Navarro, M, Osorio, A, Canzian, F, Moreno, V
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409800/ https://www.ncbi.nlm.nih.gov/pubmed/15173859 http://dx.doi.org/10.1038/sj.bjc.6601906

Ejemplares similares

Global Transcriptomic Analysis of the Canine corpus luteum (CL) During the First Half of Diestrus and Changes Induced by in vivo Inhibition of Prostaglandin Synthase 2 (PTGS2/COX2)
por: Tavares Pereira, Miguel, et al.
Publicado: (2019)

Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis
por: Vogel, Lotte K., et al.
Publicado: (2014)

Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
por: Ali, I U, et al.
Publicado: (2005)

Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model
por: Radi, Zaher A., et al.
Publicado: (2007)

Beneficial effects of cocoa on lipid peroxidation and inflammatory markers in type 2 diabetic patients and investigation of probable interactions of cocoa active ingredients with prostaglandin synthase-2 (PTGS-2/COX-2) using virtual analysis
por: Parsaeyan, Nayereh, et al.
Publicado: (2014)

Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy
por: Rawat, Chitra, et al.
Publicado: (2020)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
por: Cheng, I, et al.
Publicado: (2007)

Association study of COX-2 (PTGS2) –765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer's disease
por: Salemi, Michele, et al.
Publicado: (2014)

Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor
por: Galamb, O, et al.
Publicado: (2010)

A Meta-Analysis of PTGS1 and PTGS2 Polymorphisms and NSAID Intake on the Risk of Developing Cancer
por: Nagao, Mai, et al.
Publicado: (2013)

Prostaglandin-endoperoxide synthase 2 (PTGS2) gene expression and its association with genes regulating the VEGF signaling pathway in head and neck squamous cell carcinoma
por: Kamal, Mehta Vedant, et al.
Publicado: (2023)

Expression of cyclooxygenase-2 (COX-2) in pituitary tumours
por: Sokołowski, Grzegorz, et al.
Publicado: (2012)

The Downregulation of PTGS2 Mediated by ncRNAs is Tightly Correlated with Systemic Sclerosis-Interstitial Lung Disease
por: Xu, Zhixiao, et al.
Publicado: (2022)

Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
por: Kim, Gheun-Ho
Publicado: (2008)

Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma
por: Hubner, R A, et al.
Publicado: (2007)

Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
por: Nørregaard, Rikke, et al.
Publicado: (2015)

Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder
por: Bialek, Katarzyna, et al.
Publicado: (2020)

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease
por: Meitz, J C, et al.
Publicado: (2002)

No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations
por: Seguí, N, et al.
Publicado: (2011)

Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain
por: Wu, Tao, et al.
Publicado: (2011)

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E(2)
por: Sampey, Annaleise V, et al.
Publicado: (2005)

Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming
por: Muraoka, Naoto, et al.
Publicado: (2019)

Compensatory Prostaglandin E(2) Biosynthesis in Cyclooxygenase 1 or 2 Null Cells
por: Kirtikara, Kanyawim, et al.
Publicado: (1998)

Cyclooxygenase-2 induces angiogenesis in pancreatic cancer mediated by prostaglandin E(2)
por: Xie, Chuangao, et al.
Publicado: (2018)

The PTGS2/COX2-PGE(2) signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus
por: Martín-Vázquez, Eugenia, et al.
Publicado: (2023)

Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs
por: Yoshida, Seiya, et al.
Publicado: (2005)

Cyclooxygenase and Prostaglandin in Cancer
por: Kim, Jong-Woo
Publicado: (2012)

Upregulation of Cyclooxygenase-2/Prostaglandin E(2) (COX-2/PGE(2)) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer
por: Kochel, Tyler J., et al.
Publicado: (2016)

The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma
por: Linnebank, M, et al.
Publicado: (2004)

Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
por: Einhorn, Thomas A
Publicado: (2003)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019)

Bioactivity of dihydropyrimidinone derivatives as inhibitors of cyclooxygenase-2 (COX-2): an in silico approach
por: Haq, Kautsar Ul, et al.
Publicado: (2023)

PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model
por: Tietz, Ole, et al.
Publicado: (2016)

The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
por: Wu, Shuangshuang, et al.
Publicado: (2020)

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Sinilnikova, O M, et al.
Publicado: (2009)

Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1
por: Sasaki, Yuka, et al.
Publicado: (2015)

Isoform-Specific Compensation of Cyclooxygenase (Ptgs) Genes during Implantation and Late-Stage Pregnancy
por: Li, Xinzhi, et al.
Publicado: (2018)

The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer
por: Wang, Dingzhi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ovl3nu3tl65ahjq82ers33b9ah